Breithardt, G., Berkowitz, S., Baumgartner, H., Hellkamp, A., Piccini, J., Stevens, S., … Fox, K. (2013). OUTCOMES OF PATIENTS WITH ATRIAL FIBRILLATION AND SIGNIFICANT VALVULAR LESIONS: COMPARISON OF THE EFFECTS OF RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL. In Journal of the American College of Cardiology (Vol. 61, pp. E339–E339). Elsevier BV. https://doi.org/10.1016/s0735-1097(13)60339-3

Breithardt, Guenter, Scott Berkowitz, Helmut Baumgartner, Anne Hellkamp, Jonathan Piccini, Susanna Stevens, Yuliya Lokhnygina, et al. “OUTCOMES OF PATIENTS WITH ATRIAL FIBRILLATION AND SIGNIFICANT VALVULAR LESIONS: COMPARISON OF THE EFFECTS OF RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL.” In Journal of the American College of Cardiology, 61:E339–E339. Elsevier BV, 2013. https://doi.org/10.1016/s0735-1097(13)60339-3.

Breithardt G, Berkowitz S, Baumgartner H, Hellkamp A, Piccini J, Stevens S, et al. OUTCOMES OF PATIENTS WITH ATRIAL FIBRILLATION AND SIGNIFICANT VALVULAR LESIONS: COMPARISON OF THE EFFECTS OF RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL. In: Journal of the American College of Cardiology. Elsevier BV; 2013. p. E339–E339.

Breithardt, Guenter, et al. “OUTCOMES OF PATIENTS WITH ATRIAL FIBRILLATION AND SIGNIFICANT VALVULAR LESIONS: COMPARISON OF THE EFFECTS OF RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL.” Journal of the American College of Cardiology, vol. 61, no. 10, Elsevier BV, 2013, pp. E339–E339. Crossref, doi:10.1016/s0735-1097(13)60339-3.

Breithardt G, Berkowitz S, Baumgartner H, Hellkamp A, Piccini J, Stevens S, Lokhnygina Y, Patel M, Halperin J, Singer D, Hankey G, Hacke W, Becker R, Nessel C, Mahaffey K, Califf R, Fox K. OUTCOMES OF PATIENTS WITH ATRIAL FIBRILLATION AND SIGNIFICANT VALVULAR LESIONS: COMPARISON OF THE EFFECTS OF RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL. Journal of the American College of Cardiology. Elsevier BV; 2013. p. E339–E339.